Smoking, Cigarette
Conditions
Brief summary
The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.
Interventions
None listed
Sponsors
Foundation for a Smoke Free World INC
Rose Research Center, LLC
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
21 Years to 65 Years
Inclusion criteria
1. Has signed the ICF and is able to read and understand the information provided in the ICF. 2. Is 21 to 65 years of age (inclusive) at screening. 3. No intention of quitting smoking in the next 30 days. 4. Willing and able to comply with the requirements of the study. 5. Owns a smartphone running iOS or Android with text message and data capabilities compatible with the eResearch app.
Exclusion criteria
1. Is unhealthy or cannot participate in the study for any reason (e.g., medical, psychiatric, and/or social reason) as judged by the Investigators or designated medical staff based on all available assessments from the screening period (e.g., vital signs, physical examination, concomitant medications and medical history). 2. PHQ-9 score greater than 9, or a score greater than 0 on item #9 (Thoughts you would be better off dead, or of hurting yourself in some way) at screening. 3. Body mass index (BMI) greater than 40.0 kg/m2 4. Use of any of these products in the past 30 days: 1. Illegal drugs (or if the urine drug screen is positive for cocaine, THC, amphetamines, methamphetamines, or opiates), 2. Experimental (investigational) drugs that are unknown to participant, 3. Chronic opioid use. 5. Pregnant or nursing (by self-report) or positive urine pregnancy test. 6. Participant enrollment numbers met. \-
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| eCO Monitor Accuracy compared to COHb | Baseline | Determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples. |
| eCO Monitor's agreement with the Vitalograph BreathCO monitor | Baseline | Comparing the CO values from the eCO Monitor and the Vitalograph BreathCO monitor. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| eRESEARCH APP VALIDATION | Daily for 5 days | Validate a new mobile app called eResearch through specific functionality testing by study participants. |
Countries
United States
Outcome results
None listed